Published in Cancer Weekly, August 21st, 2001
"Patients with refractory acute leukemias after intensive induction and salvage attempts have a particularly poor prognosis and therapeutic options are limited," according to Wolfgang Kern and colleagues at the University of Munich, Carl Gustav Carus University in Dresden, Georg August University in Gottingen, Westfalische Wilhelms University in Munster, and Braunschweig's City Hospital.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.